Literature DB >> 10897157

Body dimensions of infants exposed to antiepileptic drugs in utero: observations spanning 25 years.

K Wide1, B Winbladh, T Tomson, B Källén.   

Abstract

PURPOSE: To investigate the influence of maternal antiepileptic drug (AED) treatment on pregnancy duration, birth weight, body length, head circumference, and intrauterine growth in infants exposed in utero to antiepileptic drugs in Sweden between 1973-1997, with 963 singleton infants.
METHODS: Data collected from (a) 1973-1981 (record linkage between a hospital discharge register and a medical birth register); (b) 1984-1995 (prospectively collected information in one defined catchment area with two delivery hospitals); and (c) 1995-1997 (medical birth register data). Observed numbers of infants below a defined size for body measurements compared with expected numbers calculated from all births in Sweden after stratification for year of birth, maternal age, parity, and education or smoking habits in early pregnancy. Standard deviation scores estimated with same stratification procedures.
RESULTS: Fraction of monotherapy exposures increased from approximately 40% to approximately 90% from 1973 to 1997. Significantly increased numbers of infants with small body measurements found in exposed group. Negative influence on body dimensions decreased over time. More marked effects found in infants exposed to polytherapy. In monotherapy, only infants exposed to carbamazepine consistently showed reduction in body dimensions. Significant effect on gestational age in girls and on number of small for gestational age (<2 SD) in boys.
CONCLUSIONS: Polytherapy with antiepileptic drugs and negative influence on body dimensions decreased. In monotherapy, only carbamazepine has a negative influence on body dimensions in this study.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10897157     DOI: 10.1111/j.1528-1157.2000.tb00253.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  6 in total

1.  The use of central nervous system active drugs during pregnancy.

Authors:  Bengt Källén; Natalia Borg; Margareta Reis
Journal:  Pharmaceuticals (Basel)       Date:  2013-10-10

Review 2.  Impact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research.

Authors:  Kevin G Bath; Helen E Scharfman
Journal:  Epilepsy Behav       Date:  2013-01-08       Impact factor: 2.937

3.  Generalized tonic-clonic seizures and antiepileptic drugs during pregnancy--a matter of importance for the baby?

Authors:  Markus Rauchenzauner; Margit Ehrensberger; Manuela Prieschl; Klaus Kapelari; Melanie Bergmann; Gerald Walser; Sabrina Neururer; Iris Unterberger; Gerhard Luef
Journal:  J Neurol       Date:  2012-09-07       Impact factor: 4.849

4.  Postnatal onset of severe growth retardation after in utero exposure to carbamazepine and phenobarbital: a case report.

Authors:  Alice Liguori; Stefano Cianfarani
Journal:  J Med Case Rep       Date:  2009-06-12

5.  Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health.

Authors:  Barbara Mostacci; Francesca Bisulli; Elisabetta Poluzzi; Guido Cocchi; Carlo Piccinni; Alessandra Curti; Giuliana Simonazzi; Gianni Astolfi; Nicola Rizzo; Corrado Zenesini; Roberto D'Alessandro; Paolo Tinuper
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-03-16       Impact factor: 10.154

6.  Relation of in-utero exposure to antiepileptic drugs to pregnancy duration and size at birth.

Authors:  Andrea V Margulis; Sonia Hernandez-Diaz; Thomas McElrath; Kenneth J Rothman; Estel Plana; Catarina Almqvist; Brian M D'Onofrio; Anna Sara Oberg
Journal:  PLoS One       Date:  2019-08-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.